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ABSTRACT
Objectives To establish the feasibility of a definitive 
randomised controlled trial of Systemic Autism- related 
Family Enabling (SAFE), an intervention for families of 
children with autism.
Design A randomised, controlled, multicentred feasibility 
study.
Setting Participants were identified from three National 
Health Service (NHS) diagnosing centres in Plymouth and 
Cornwall and a community pathway.
Participants 34 families of a child with a diagnosis of 
autism severity level 1 or 2 between 3 and 16 years. Four 
families were lost to follow- up.
Interventions SAFE is a manualised five- session family 
therapy- based intervention delivered over 16 weeks 
and designed for families of children with autism. SAFE 
involves families attending five 3- hour sessions led by 
systemic practitioners.
Primary and secondary outcome measures The 
proposed primary outcome measure was the Systemic 
CORE 15 (SCORE-15). Proposed secondary outcome 
measures: Patient Health Questionnaire- Somatic Anxiety 
Depressive Symptoms, the Coding of Attachment- Related 
Parenting for use with children with Autism, the Child 
Behaviour Checklist (CBCL), the Reflective Functioning 
Questionnaire (RFQ) and the Caregiving Helplessness 
Questionnaire. Outcome measures were collected at 
baseline and 24 weeks post randomisation.
Results All primary caregivers retained in the study 
completed the SCORE-15 at both time points. 34 of the 
target of 36 families were recruited and 88% of families 
were retained. Training for therapists was effective. 
Feedback revealed willingness to undergo randomisation. 
There was 100% attendance at appropriate sessions for 
core family members. The SCORE-15 showed reduction in 
scores for families receiving SAFE compared with controls 
suggesting positive change. Qualitative data also revealed 
that families found the study acceptable and families 
receiving SAFE experienced positive change. Feedback 
indicated that the SCORE-15 should be retained as a 
primary measure in a future trial, but secondary measures 
should be reduced.
Conclusions This study indicates that a larger trial of 
SAFE is feasible. Findings suggest that SAFE can address 
current gaps in recommended care, can be confidently 
delivered by NHS staff and has potential as a beneficial 
treatment.
Trial registration numbers ISCTRN83964946 and 
IRAS213527.
INTRODUCTION
More than 1% of the UK population has a 
diagnosis of autism.1 Families of children with 
a diagnosis of autism present complex needs. 
Children with autism have impairments in 
social communication and restricted, repet-
itive behaviours and interests.2 Autism is 
widely accepted to have a genetic compo-
nent and the broader autism phenotype is 
disproportionally represented among family 
members.3 Mental health problems are expe-
rienced by more than 70% of individuals with 
autism and more than 50% of their parents.4 5 
Parents of children with autism are more likely 
to be hospitalised for mental disorders than 
parents of typically developing children6 
and mothers of children with autism are 
reported to have higher unmet needs, more 
difficulties coping and lower satisfaction with 
Strengths and limitations of this study
 ► The study addressed a gap in the available research 
data, and produced important feasibility information 
to inform a fully powered randomised controlled 
trial.
 ► The study explored the feasibility of using measures 
of family function and a range of mental health 
measures.
 ► Quantitative feasibility data were complemented by 
qualitative focus groups and interviews.
 ► The study explored the feasibility of economic anal-
ysis measures in a population, which includes adults 
and their children with developmental disorders.
 ► The participants were recruited from two National 
Health Service Trusts in adjacent counties in the 
South West of England, leading to potential bias. 
A future randomised controlled trial will extend to 
centres across the UK including Scotland and Wales.
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service interactions than mothers of children with other 
disabilities.7
As these families often exhibit psychological morbidi-
ties alongside autism in the children, costs of services to 
treat these problems are high.8 9 Furthermore, untreated 
or unresponsive mental health problems impose societal 
costs making it hard for parents to interact effectively 
with services,10 potentially worsening outcomes for chil-
dren and exacerbating the substantial economic burden 
of autism.9
Explanations for high levels of affective disorders in 
these families include: stress associated with the condition 
of autism, genetic factors and intergenerational family 
dynamics. Parenting children with autism involves stresses 
associated with challenging behaviour, communicative 
difficulties, isolation and atypical attachment behaviour 
displayed by children.11 In addition, these parents suffer 
from poorer quality of life, and higher levels of stress 
compared with other populations due to societal issues 
including stigma, unemployment and difficulty accessing 
support.12 13 Parents of children with autism report that a 
consequent lack of psychological well- being exacerbates 
maladaptive behaviour in their children,14 which is likely 
to result in unhelpful cycles of distress and hopelessness.
Previous research demonstrates that experience of 
trauma and abuse among women is associated with 
elevated risk of autism developing in their subsequent 
offspring.15 16 Hence, it is possible that mothers of chil-
dren with autism are more likely than the general popula-
tion to be coping with previous traumatic events. Families 
of children with autism can experience positive family 
life, cope well with difficulties and enjoy good relation-
ships with their children,17 but they represent a high- risk 
group, for whom treatment is disjointed, costly and inad-
equate.18 19
A more joined- up approach is required, focusing on 
communication within families, strategies for coping 
with challenging behaviour and associated problems 
and building on strengths and relationships to alleviate 
mental health difficulties. The current study should be 
placed in the context of international calls for improved 
services and care for families of children with autism at 
country level,20 alongside National Institute for Health 
and Care Excellence (NICE) guidelines and recommen-
dations,21 22 as well as developments regarding children’s 
service provision proposed by the Monroe report.23 24 
Families of children with autism themselves highlight the 
importance of professionals working therapeutically with 
children and the wider family.6
Systemic Autism- related Family Enabling (SAFE) is a 
systemic family therapy approach designed to address 
autism- related needs including problem- solving, poor 
sociocommunication, mental health difficulties and 
challenging behaviour.25 Systemic family therapy is a 
well- recognised, evidence- based psychotherapeutic 
approach.26 Despite evidence that family therapies 
can provide benefits to children with autism and their 
parents27 28 its efficacy for addressing challenges associated 
with this condition has not been subject to a randomised 
controlled trial. In addition, existing research over-
whelmingly shows that families of children with autism 
want interventions which make real improvements to 
their daily life and sense of well- being.29 30
Patient and public involvement
This study grew from the articulated needs of over 90 
families surveyed and interviewed through the Plymouth 
Autism Network, specifically the lack of support postdi-
agnosis and the need for support for the whole family. 
The main aim was to develop a family- orientated support 
package and conduct a feasibility study, definitive trial 
and ultimately implement an intervention to be offered 
to all families after diagnosis. To achieve this aim in a 
sustainable manner we included families as partners at 
every stage of design and application.
Prior to commencement of the trial a pilot study was 
conducted with families acting as consultants. From the 
pilot, we recruited interested families to form the SAFE 
Family Consultation Group. Their representative was 
a coapplicant on the initial bid and was employed as a 
research assistant. The consultation group were consulted 
at every stage of the trial including the initial application, 
developing, refining and administering the intervention, 
developing trial materials, recruitment, training and 
dissemination.
The family representative attended all trial manage-
ment and research meetings and took part in all training. 
She disseminated to consultation group members and 
where appropriate, meetings with the wider group were 
held. The input from the families has been invaluable in 
engaging participants and ensuring their well- being.
Patient and public involvement (PPI) was an intrinsic 
part of this study and our continued positive engagement 
and partnership with families of children with autism 
is a strength. The research emerged from the difficul-
ties articulated by families and we worked with them to 
develop solutions. We feel that this way of working made 
a substantial impact on the outcomes for the families 
receiving the intervention and the fact that the feedback 
from families was overwhelmingly positive. We also believe 
that PPI ensured a more ethical and thorough study 
which did not lose sight of the ultimate aim. The input 
of families throughout provided considerable motivation 
for the research team in delivering the study despite the 
challenges faced.
Aims and objectives
The aim of the study was to establish the feasibility of a 
definitive randomised controlled trial of SAFE.
Our objectives were to:
1. Demonstrate ability to identify, recruit and randomise 
eligible families.
2. Verify that proposed outcome measures and follow- up 
were acceptable, and targets for loss to follow- up were 
achievable.
3. Assess adherence of families to the intervention.
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4. Gather quantitative data on outcomes to inform the 
design (and sample size) of the future trial.
5. Adapt existing Resource Use Questionnaire (RUQ) 
and assess the feasibility of preference based instru-
ments for this population to facilitate a future econom-
ic evaluation.
6. As part of the feasibility of process evaluation, collect 
data on the families’ experience of SAFE and the study 
itself.
7. As part of the feasibility of process evaluation, ensure 
that proposed training arrangements were effective 
and scalable.
8. Provide operational experience to manage the future 
trial.
METHODS AND ANALYSIS
The study comprised a randomised, controlled, multi-
centred feasibility study including families of children 
with a diagnosis of autism.25
Participants
Participants were identified from three National Health 
Service (NHS) diagnosing centres in Plymouth and Corn-
wall via a search of clinical records or recruitment directly 
after diagnosis. A community recruitment pathway was 
added after commencement of the study to alleviate the 
burden on clinical staff and increase participation. Fami-
lies were recruited by posters in local community venues.
Eligibility was determined by diagnosing clinicians 
or from clinical records or diagnostic letter as well as 
discussion with the family. A member of the research 
team gained consent during the first home visit. Pilot 
data suggested that SAFE was most effective and acces-
sible for children without severe symptoms or an intel-
lectual impairment. Children with severe communication 
difficulties found it difficult to engage with some SAFE 
activities. For this feasibility study, therefore, our target 
population was families of children with autism severity 
level 1 or 2 with no intellectual impairment.
Eligibility criteria
 ► Family included child with autism, aged 3–16 years.
 ► Diagnosis of Autism Spectrum Disorder (ASD) 
severity level 1 or 2 as documented in Diagnostic and 
Statistical Manual of Mental Disorders, Fifth Edition 
(DSM-5).2
 ► Diagnosed within 12 months of consenting to the 
study.
 ► If other diagnoses were present, ASD must be primary 
diagnosis.
 ► Families were willing to comply with study 
requirements.
Exclusion criteria
 ► Child with ASD severity level 3 as documented in 
DSM-5.2
 ► Child with ASD and intellectual impairment.
 ► Serious concomitant illness in child or family, or other 
circumstances such that they were unable to comply 
with study requirements.
 ► Families who may have been a risk to safety of research 
staff.
 ► Insufficient English language, or capacity for parent/
child to consent/assent to the study.
The intervention
SAFE is a manualised intensive programme of systemic 
family therapy designed to treat maladaptive autistic symp-
toms and mental health- related difficulties encountered 
by families of children with autism (online supplemental 
appendix 1). SAFE lead therapists were qualified NHS 
systemic practitioners who received an additional 4- day 
training course in SAFE principles and delivery. Each lead 
therapist was accompanied by a support therapist trained 
in SAFE. SAFE provides an array of therapeutic activities 
based on attachment theory, established systemic practice 
and the known visual processing preferences of people 
with autism.31 32 SAFE is best seen as a toolkit with a variety 
of activities which can be applied to family therapy flex-
ibly. Activities include visual tasks, drawing, modelling, 
role- play and tracking circular patterns. Sessions are led 
by family need and the therapists and family work collab-
oratively, often in a playful way, using family resources, 
therapist expertise and the tools that SAFE provides. 
SAFE draws heavily from well- documented active and 
playful approaches in family therapy practice and liter-
ature.33 Each therapy session included two therapists 
with a minimum of intermediate family therapy level 
of qualification and 4 days training in SAFE principles. 
Between weeks 1 and 16, families allocated to the SAFE 
intervention attended five 3- hour SAFE therapy sessions. 
Sessions 1 and 5 were multifamily sessions and took place 
in a community setting. Sessions 2, 3 and 4 were for indi-
vidual families and took place in a community venue or 
the family home. Following completion of the therapy 
programme, families attended a group follow- up session 
at 24 weeks postallocation. Trained support workers from 
local voluntary groups attended this follow- up session and 
gave the families information about continued support 
through existing networks.
Support as usually employed
Families were typically offered a postdiagnosis follow- up 
appointment with the diagnosing paediatrician.
Parents of children whose symptoms were not severe 
tended to be directed to local authority parenting classes. 
In some cases, families were also directed to relevant 
resources, for example, The National Autism Society, 
Gateway ASD and the NHS Child and Adolescent Mental 
Health Services. For families where a member was experi-
encing depression or anxiety, treatment varied and was not 
linked to autism- related care. Referral was often through 
the general practitioner with patients receiving cognitive 
behavioural therapy as part of the improved access for 
psychological therapies service and or medication.
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Procedure
Families were recruited in four cohorts of between 6 
and 12 families (two cohorts from Plymouth and two 
from Cornwall). Postbaseline, once sufficient families 
had been recruited to establish a cohort, families were 
randomised 2:1 to the SAFE intervention plus Support 
as Usually Employed (SAFE +SUE) or SUE only. Rando-
misation was undertaken by a member of the Peninsula 
Clinical Trials Unit (CTU) programming team by means 
of a 24- hour web- based system created by the CTU in 
conjunction with a statistician independent from the 
trial team, and used random permuted blocks, with strat-
ification by study site. Twenty- two families were allocated 
to SAFE +SUE and 12 families were allocated to SUE 
(see figure 1). Clinical staff and research staff collecting 
outcome data were blinded to allocation. Those in the 
intervention arm received a preparatory home visit from 
a therapist.
Outcome measure data were collected at baseline 
and 24 weeks postrandomisation. Additional data were 
collected from the intervention participants: post alloca-
tion, at each therapy session and at the feedback day (see 
figure 1).
Feasibility outcome measures
 ► Ability to identify, recruit and randomise eligible 
families.
 ► Acceptability of proposed outcome measures and 
follow- up schedule to participants, and whether 
targets for loss to follow- up were achievable.
 ► Adherence of therapists and families to the 
intervention.
 ► Ability to gather quantitative data on outcomes.
 ► Appropriateness of RUQ and preference- based instru-
ments for this population.
 ► Effectiveness and scalability of training arrangements.
Clinical outcome measures
The proposed primary outcome measure was, the 
Systemic CORE 15 (SCORE-15).34 This is a 15- item paper- 
based survey made up of three subcategories. For each 
item scores range from 1 to 5. The potential range of 
overall scores is 15 to 75, with a lower score indicating 
higher family functioning. Based on available literature,35 
a meaningful change in family function, from preinter-
vention to postintervention, would be solidly indicated 
by a reduction of 3 on overall scores. The SCORE is the 
primary measure of family functioning employed in Chil-
dren and Young People’s Improving Access to Psycho-
logical Therapies national programme, and is the gold 
standard for assessing the impact of family therapy on 
quality of life in the UK.36 Every able family member was 
asked to complete the SCORE-15 at baseline and 24 weeks 
postrandomisation.
The SCORE-15 is particularly well suited as a primary 
measure for this study as it is a measure for the whole 
family and, like SAFE, it has a systemic framework based 
on the premise that relational dynamics are central to the 
well- being of all family members. In addition, the three 
dimensions of SAFE are well matched to the needs of this 
population in that the SCORE-15 is sensitive to change in 
aspects of mental health and problem solving defined by 
the three subcategories measuring: family strengths, resil-
ience and coping (Strengths and Adaptability); commu-
nication and understanding within the family (Disrupted 
Communication) and changes in ability to manage prob-
lems (Overwhelmed by Difficulties). The SCORE also 
correlates with measures of parental satisfaction, mental 
health, strengths and difficulties and life satisfaction.37
Scores on the proposed secondary outcome measures, 
which index changes in child behaviour, child–parent 
attachment, anxiety and depression:
 ► Patient Health Questionnaire (PHQ)- Somatic Anxiety 
Depressive Symptoms completed by parents. This 
comprises the PHQ-9 measuring depression and the 
Generalised Anxiety Disorder (GAD-7) measuring 
anxiety.38
 ► Adapted mutuality subscale of the Coding of 
Attachment- Related Parenting for use with children 
with Autism (CARP- A)39 completed by the whole 
family. The CARP- A is a validated observational 
measure of a child with autism’s attachment behaviour 
Figure 1 Participant flow diagram (CONSORT). CONSORT, 
Consolidated Standards of Reporting Trials; CWA, child with 
a diagnosis of autism; PCG, primary caregiver; PDI, parent 
development interview; SAFE, Systemic Autism- related 
Family Enabling; SCORE, Systemic CORE 15.
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towards their carer. The measure was adapted to form 
a family Lego ‘building your house’ task.
 ► The CBCL40 completed by the Primary Caregiver. 
This is a 30- item paper- based survey, which detects 
emotional and behavioural problems.
 ► The RFQ40 completed by parents, measures ability to 
understand own and others’ mental states.
 ► Caregiving Helplessness Questionnaire (CGHQ)41 
completed by the parents. This is a 26- item ques-
tionnaire designed to assess aspects of disorganised 
caregiving.
Scores on proposed generic health economic outcome 
measures also provided data on the feasibility of cost- 
effectiveness analysis:
 ► EuroQol 5 dimensions (EQ- 5D), a standardised 
generic instrument for measuring health outcome.
 ► Child Health Utility 9 Dimensions (CHU- 9D), a paedi-
atric generic preference- based measure of health- 
related quality of life.
 ► RUQ, a paper- based questionnaire completed by 
parent about his/her child’s use of healthcare and 
social resources. The RUQ is designed to identify the 
NHS and social care resource use for the economic 
evaluation.
Proposed qualitative outcomes assessed via focus groups
Proposed qualitative outcomes assessed via focus groups:
 ► Acceptability of SAFE and the trial process for partici-
pants and therapists.
 ► Reasons for declining and withdrawing from the study.
Additional process measures completed after each 
SAFE session by therapists and families allocated to SAFE:
 ► The Client Satisfaction Questionnaire (CSQ-8 
completed by families).
 ► Helpful Aspects of Therapy Questionnaire—assessing 
what was helpful/unhelpful in each session (HAT 
completed by families).
 ► The Training Checklist and Questionnaire monitoring 
protocol adherence (TCQ completed by therapists).
Quantitative analysis
Prior to analysis a detailed statistical analysis plan was 
created and agreed by the research team. For each 
outcome measure, the relevant scores were calculated 
and presented descriptively by trial arm.
Where available, published guidelines were used to 
process, score and summarise the measures including 
the use of imputation in the event of missing items on 
a questionnaire. Summary measures were calculated as 
appropriate, for example, means and SD, medians and 
ranges, numbers and percentages in categories. The only 
analysis contrasting the two groups was an interval esti-
mate in the form of a 95% CI for the primary outcome, 
the SCORE-15.
Qualitative analysis
Prior to analysis a qualitative analysis plan was agreed. 
Focus group interviews were conducted for SAFE 
+SUE and SUE families from each cohort after the 24 
weeks outcome data had been collected for that cohort. 
Focus groups were audio recorded and transcribed 
verbatim. Consequent qualitative data were managed 
using proprietary computer- assisted qualitative data anal-
ysis software, NVivo V.10, and analysed thematically.42 43 
Summaries of process measures were compiled including 
quantitative data from Likert scales and thematic analysis 
of open- ended questions. Subsequently, independent 
analysis of qualitative data was conducted, including 
notes and memos, on a subset of the data by two of the 
authors and consensus reached on overarching themes 
relating to family experience of SAFE.
RESULTS
Recruitment and randomisation
Of 138 families screened, 106 were eligible and 32 inel-
igible. Forty- five eligible families expressed interest of 
which 34 were recruited (figure 1). Since randomisation 
only occurred once a complete cohort (between 6 and 
12 families at each site) was recruited, the time between 
consent (when baseline questionnaires were completed) 
and randomisation varied. Data on relevant dates were 
available for 33 families, for whom there was a median 
(range) of 21 days (2–111) between baseline question-
naire completion and randomisation, with a mean (SD) 
of 34 (32) days. Nineteen families completed the 24- week 
assessments for which dates were available. Six of the 19 
dates were less than 22 weeks from randomisation due 
to time constraints, none were more than 26 weeks. All 
primary caregivers were mothers and there were three 
single parent families (two allocated to SAFE+SUE and 
one allocated to SUE). Baseline demographics were 
similar for children with autism in both groups (See 
table 1). Baseline constitution of families varied and are 
shown in table 2.
Table 1 Summary statistics of baseline and demographic 
characteristics for children with autism
  
SAFE+SUE 
(n=22) SUE (n=12)
Total 
(n=34)
Age
  Mean (SD) 9.5 (2.7) 9.4 (2.4) 9.5 (2.5)
  Median (range) 10 (5–14) 9 (6–13) 10 (5–14)
Gender n (%)
  Male 17 (77) 9 (75) 26 (76)
  Female 5 (22) 3 (25) 8 (24)
Ethnicity n (%)
  White 22 (100) 12 (100) 34 (100)
SAFE, Systemic Autism- related Family Enabling; SUE, Support as 
Usually Employed.
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Acceptability of outcome measures and follow-up schedule 
and lost to follow-up
One SUE family was lost to follow- up and three SAFE+SUE 
families were lost to follow- up (figure 1). Mechanisms 
were in place to report and record serious adverse events 
(SAEs) related to mental health from consent until 
participants completed the follow- up or withdrew from 
the study. No SAEs were reported.
For the purposes of the study, the core family was taken 
to be the primary caregiver (all mothers) and children 
with autism. In one case, parents were joint primary care-
givers. Families chose who else would attend sessions and 
complete data. At baseline, 34 families and 122 family 
members provided data. At the 24- week assessment, 30 
families and 97 family members provided data. Different 
outcomes are completed by different combinations of 
family members. The primary caregiver provided data on 
all measures at baseline, and 22 of the 23 other caregivers 
(fathers) did likewise. There was a small number of care-
givers who did not provide data at 24 weeks for some ques-
tionnaires. The completion of the SCORE by the children 
with autism and siblings was optional. Reasons for non- 
completion by the child with autism were: child was too 
young (n=4), the visit could not be arranged (n=1), the 
child did not want to (n=1) and reason unknown (n=1) 
(see figure 1).
Adherence of families to the intervention
Full engagement with the SAFE intervention involved 
five 3- hour therapy sessions. The first and last of which 
were multifamily sessions for the parents (children could 
attend if they wished) between weeks 1 and 16, with a 
final feedback day at 22 weeks. The primary caregiver was 
present for these sessions, except for one mother who was 
absent for session 1, but the father attended. The child 
with autism was always present at the individual sessions 
2–4. Five children were also present at parent sessions 1 
and 5.
Quantitative data on outcomes
Results for the SCORE-15, including expressions of uncer-
tainty (95% CI) for estimates by randomised groups are 
shown in table 3. In general there is no specific guidance 
available on how to handle missing data for the outcome 
measures used. In what follows, a decision was made to use 
an individual’s total score data if there was no more than 
one missing item, for which the mean of the other items 
was imputed. If there were totals for subgroups, these 
were included if there was no more than one missing item 
within each subgroup, for which the mean of the other 
items within the subgroup were imputed.
Feasibility of using economic evaluation instruments for this 
population
Completeness of health economics data was achieved 
in intervention and control groups for the primary care 
based, community based and mental health based services 
at 100% response rate at baseline dropping to 82% and 
83% at 24 weeks in intervention and control groups, 
respectively. The outpatient- based services had response 
rates of 68% and 67% at baseline, but completeness 
improved to 82% and 83% in intervention and control 
groups, respectively, at 24 weeks.
For EQ- 5D-5 level, at baseline the control group had a 
100% response rate. At 24 weeks the response rates were 
82% and 83% of participants in intervention and control 
groups, respectively.
As expected CHU- 9D responses were largely provided 
by children with autism (completed by the primary care-
giver where necessary). Response rate in the intervention 
group fell from 77% to 73% for children with autism but 
remained constant with three (14%) primary caregiver 
responses at baseline and 24 weeks. In the control group, 
response rate fell from 83% to 58% in children with autism 
and 25% to 17% in Primary Caregivers (mothers) from 
baseline to week 24. Despite indications for increased 
appropriate service use coupled with reduced cost over 
time for SAFE+SUE children with autism, the economic 
evaluation focused only on children with autism, conse-
quently insufficient data was collected for whole family 
service use and costs.
The families’ experience of the study and the SAFE 
intervention
Qualitative data on the experience of the study were 
collected from SAFE+SUE and SUE families in family 
feedback days for each cohort. Key areas revealed by 
analysis of the data were (1) the study was not burden-
some, (2) that they took part to help others, (3) research 
Table 2 Constitution of families at baseline
Family members in addition to 
child with autism
No families 
SAFE+SUE
No 
families 
SUE
No 
families 
total
Mother (only) 2 1 3
Mother + 1 sibling 2 0 2
Mother + 2 siblings 1 0 1
Mother + 3 siblings 2 0 2
Mother + 4 siblings 2 0 2
Mother + father 0 4 4
Mother + father + 1 sibling 6 4 10
Mother + father + 2 siblings 3 1 4
Mother + father + 3 siblings 1 1 2
Mother + father + 4 siblings 0 1 1
Mother + father + grandmother + 
grandfather
1 0 1
Mother + father + grandmother + 
grandfather + 1 sibling
1 0 1
Mother + 3 siblings +1 nephew 1 0 1
SAFE, Systemic Autism- related Family Enabling; SUE, Support as 
Usually Employed.
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staff made completing tasks easier and sessions could be 
organised differently.
The families did not find the completion of CARP- A 
Lego task and questionnaires onerous:
didn’t mind so much doing like the Lego task I mean 
like it’s something that we like to do anyway … but 
um the questionnaires didn't have a problem with 
those either
Families felt that there were too many questionnaires, 
but the approachable nature of the research staff made 
the task easier:
it was all fine … it was A [Research Assistant] that 
came in did it and she’s so friendly and approachable 
that it made it easy…
Families generally took part in the study for altruistic 
reasons. They wanted to be part of a study which could 
potentially increase support postdiagnosis. Feedback 
from SUE families suggested that this helped them to 
accept their role in the study:
I thought actually this could be a way of helping fu-
ture parents of diagnosed children to get the sup-
port and advice that wasn’t there when I got the 
diagnosis
The focus group data also revealed that families felt 
sessions at home were too distracting, the sessions should 
be shorter, but more of them and more activities for 
younger children were needed.
Where families were allocated to the intervention, data 
on family experience of SAFE were collected via process 
evaluation measures, the HAT and the CSQ completed 
by family members after each therapy session and via the 
family feedback day. Quantitative data from the HAT indi-
cated that SAFE families found the intervention helpful 
with mean scores for all sessions on the HAT being rated 
by children and adults as helpful or very helpful. Analysis 
of all qualitative data from process measures and the feed-
back day resulted in the following overarching themes: 
therapist helping reflection, increased understanding, 
feeling closer, feeling more confident, more able to 
Table 3 Values for SCORE-15, based on the ‘total’ computed for each dimension and overall for each person
  
Baseline 24 weeks post randomisation
Difference*
N
SAFE+SUE SUE SAFE+SUE SUE
Mean SD Mean SD Mean SD Mean SD 95% CI
Strengths and adaptability
  CWA 11.4 3.3 12.8 3.9 12.1 4.0 12.6 4.8 −3.81 to 3.29 21
  Primary CG 10.0 2.7 9.4 2.3 10.9 3.1 10.6 2.3 −1.96 to 1.92 30
  Other† 11.0 3.6 10.2 3.0 11.1 3.9 11.2 4.6 −1.59 to 3.87 43
  Whole family† 10.8 3.3 10.5 3.2 11.2 3.7 11.3 3.9 −0.89 to 2.07 94
Overwhelmed by difficulties
  CWA 12.3 3.9 12.3 5.5 13.5 4.2 14.1 5.5 −2.89 to 5.58 21
  Primary CG 12.4 3.5 12.1 4.0 11.5 2.7 12.7 4.1 −0.69 to 3.79 30
  Other† 12.1 3.9 12.2 3.9 11.7 3.2 13.1 4.2 −0.63 to 3.86 43
  Whole family† 12.2 3.7 12.2 4.2 12.1 3.4 13.2 4.4 −0.03 to 2.96 94
Disrupted communication
  CWA 12.8 4.3 11.8 4.0 13.2 4.4 11.4 2.9 −5.02 to 3.08 21
  Primary CG 11.9 4.8 9.6 2.8 10.2 2.6 9.6 2.5 −1.95 to 2.04 30
  Other† 12.9 4.6 12.6 4.2 12.3 3.4 11.2 3.6 −2.91 to 1.59 43
  Whole family† 12.6 4.5 11.5 3.9 11.9 3.6 10.7 3.1 −2.03 to 0.92 94
Overall score
  CWA 36.4 10.1 36.8 11.9 38.8 11.3 38.1 12.0 −9.68 to 11.22 21
  Primary CG 34.3 9.7 31.1 7.6 32.5 7.2 33.0 7.9 −3.49 to 7.35 30
  Other† 36.1 10.2 34.9 9.5 35.1 7.5 35.5 10.4 −3.81 to 7.24 43
  Whole family† 35.7 9.7 34.1 9.5 35.2 8.6 35.2 9.8 −2.09 to 5.26 94
Reduction in values and positive differences in 95% CIs indicate positive change.
*Difference between SUE and SAFE +SUE at 24 weeks follow- up, adjusting for baseline in ANCOVA, based on individuals with complete data 
at both baseline and 24 weeks assessment; no allowance for hierarchy of data.
†Scores averaged across all relevant family members.
ANCOVA, analysis of covariance; CG, caregiver; CWA, child with a diagnosis of autism; SAFE, Systemic Autism- related Family Enabling; 
SCORE15, Systemic CORE 15; SUE, Support as Usually Employed.
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reflect and problem solve, improved communication and 
feeling less isolated.
The multifamily sessions made families feel less alone, 
more able to talk about difficult issues and less judged.
Talking to other parents and feeling listened to and 
supported
Talking about daily issues and sharing these with the 
other parents, generally feeling that I am not alone
Families reported being able to step back and reflect, 
leading to more confidence in tackling family problems.
Breaking down problem events and looking at caus-
es, outcomes, choices made. Compared a recent to 
past events and saw progress and maturity in decision 
making and actions
SAFE therapists were seen as allies and the activities 
helped with family problems leading to increased under-
standing and improved mental health:
Actually being able to hear that I'm doing OK and 
actually not as bad as what I thought I was, was nice. 
It was something that helped me with my mental and 
emotional state
Effectiveness and scalability of training
The therapists completed the TCQ after each session 
informing the potential for future scalability and estab-
lishing that training methods were effective. The TCQ 
was a short questionnaire documenting adherence to 
planned activities in each session, confidence and ease 
of delivering activities, rating of the effectiveness of activ-
ities and any additional resources required. Focus groups 
and interviews were also conducted with the therapists 
after completion of the intervention. The therapists felt 
that SAFE was an inspirational and effective intervention, 
was non- pathologising and child centred. The training 
was motivational and thorough. In 82% of sessions lead 
therapists reported feeling confident, that the sessions 
were effective and the activities were easy to deliver. The 
support therapists, who were less experienced, felt confi-
dent, that sessions were effective and activities easy to 
deliver in 63% of sessions. The therapists felt supervision 
was very helpful. They highlighted that the gap between 
training and intervention was too long.
Operational experience moving forward
The chief investigator (CI) kept the study on time and 
within budget despite multiple challenges. The support 
and advice of the trial steering committee, the PenCTU 
and the research team facilitated the development of the 
skill set of the CI in preparation for a definitive trial.
DISCUSSION
To our knowledge, this study is unique in evaluating the 
feasibility and efficacy of a family therapy- based interven-
tion designed specifically for families of children with a 
diagnosis of autism. The results indicate that a larger trial 
of SAFE would be feasible. The findings also suggest that 
offering SAFE for families postdiagnosis is both feasible 
and potentially efficacious.
Progression to a definitive trial was supported based on 
predetermined criteria met in the following ways: (1) 34 
of the target of 36 families were recruited. Family feed-
back revealed willingness to undergo randomisation as 
families felt the study had potential to extend services, (2) 
88% of families were retained, (3) There was 100% atten-
dance at appropriate sessions for core family members, 
(4) For the SCORE-15, complete data were available 
at both time points and for every dimension for 88% 
primary caregivers, 62% children with autism and 55% 
other family members. All primary caregivers retained in 
the study completed the SCORE-15 at both time points, 
(5) Collecting health and social care resource utilisation 
data and health- related quality of life data for children 
with autism was feasible, (6) Process evaluation and feed-
back day showed that in 82% of sessions lead therapists felt 
confident, that sessions were effective and easy to deliver 
and (7) The qualitative and process data from families 
indicates tentative potential for efficacy as SAFE was rated 
as helpful or very helpful in addressing problems. Qual-
itative analysis revealed the following themes of positive 
change: therapist helping reflection, increased under-
standing, feeling closer, feeling more confident, more 
able to reflect and problem solve, improved communica-
tion and feeling less isolated. A common thread across all 
qualitative data was increased mental well- being among 
family members receiving SAFE. Although we acknowl-
edge that the current study was not powered to detect 
a difference, the SCORE-15 showed marked reduction 
in scores for SAFE+SUE suggesting positive change. A 
reduction of this magnitude indicates tentative potential 
proof of efficacy34 35 (see figure 2).
Figure 2 Mean change in SCORE-15 subcategories for 
SAFE+SUE (SAFE) and SUE only (control) for all family 
members, including children with autism, who completed 
the SCORE-15 at both baseline and at 24 weeks. SAFE, 
Systemic Autism- related Family Enabling; SCORE-15, 
Systemic CORE 15; SUE, Support as Usually Employed.
by copyright.
 on D
ecem
ber 31, 2020 at U
niversity of P
lym
outh. P
rotected
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2020-038411 on 31 D
ecem
ber 2020. D
ow
nloaded from
 
9McKenzie R, et al. BMJ Open 2020;10:e038411. doi:10.1136/bmjopen-2020-038411
Open access
Additional analysis of the SCORE-15 data revealed that 
the most marked indications of positive change were 
experienced by Primary Caregivers with high anxiety as 
measured by the GAD-7 scale. The relationship between 
anxiety scores and values on the SCORE-15 is important 
as SAFE seeks to alleviate mental health issues. An indi-
cation that a reduction in anxiety and improved family 
function can be captured by our proposed measures and 
that data suggests positive change for those participants 
with acute difficulties receiving the intervention is there-
fore promising (see figure 3).
The sample size calculation for a subsequent fully 
powered randomised controlled trial is based on the 
SCORE-15 for primary caregivers, which will be the 
primary outcome in the full trial. The minimal clinically 
important difference of 3 is based on the literature35 and 
an SD of 8 is based on an SD of 7.3 obtained from the 
feasibility study. To account for a possible group effect in 
the intervention group, we will use a conservative 0.1 for 
the intragroup correlation and an assumed mean group 
size of 6 with variance 2. Employing the conventional two- 
sided 5% alpha and 90% power, and retaining the 2:1 
allocation, gives a requirement for 405 evaluable partic-
ipants. Using the drop- out experienced in the feasibility 
study would increase the requirement to 460.
The feasibility study alongside previous research4–7 
strongly suggests that these families are an at- risk group 
who experience very limited support post diagnosis. One 
of the primary aims will be to carry out a definitive trial 
in order to address international20 and national recom-
mended good practice in relation to children with 
autism and their families (NICE guidelines).21 22 These 
recommend psychosocial interventions, which improve 
sensitivity, responsiveness and communication within 
families. They also call for interventions which prevent 
challenging behaviour by creating care packages which 
address coexisting mental health problems, and provide 
support for families. NICE guidelines associated with 
child mental health also ask for the provision of psycho-
logical therapies including family therapy; the need for 
parents’ psychiatric problems to be treated, for children’s 
mental health to improve; and management of develop-
mental conditions to be in parallel with mental health 
interventions.
NICE research recommendations associated with autism 
call for randomised controlled trials exploring family 
interventions that are designed to reduce challenging 
behaviour, alleviate stress and improve quality of life.21 
Our long- term goals are also informed by the Munroe 
report,44 which called for children’s services to offer 
family- centred, therapeutic intervention rather than risk 
management. Additionally, the current implementation 
of the improved access to psychological therapies scheme 
for children45 promotes proactive attachment- based and 
family therapy approaches. SAFE has the potential to 
address this gap by providing a family- based intervention 
which is sustainable, extends existing services and is bene-
ficial to families.
LIMITATIONS
Use of the primary measure the SCORE-15 was limited 
for children below 7 years and an adapted more visual 
version will be developed so children below 7 years can 
contribute. The economic evaluation focused solely on 
the child with a diagnosis. To ensure sufficient data is 
collected, a subsequent trial should include longer- term 
service use and costs for all family members. Families felt 
there were too many measures and repetition. For any 
subsequent trial the outcome measures would be reduced 
and adapted. The RFQ replicated information from other 
measures and the CBCL was lengthy and complex. These 
measures would not be used in a subsequent trial. We 
propose the SCORE-15 (measuring perceived change in 
family functioning) be retained as our primary outcome 
measure for primary caregiver alongside secondary 
measures being the adapted SCORE-15 (for other family 
members including the youngest children), PHQ- SADS 
(anxiety scale), CGHQ (measuring change in caregiver 
helplessness) and the CARP- A (measuring mutuality 
between family members).
Recruitment and organisation of SAFE sessions was 
challenging. There was large variability in the times-
cales between baseline and start of intervention. In any 
subsequent trial waiting could be managed by carrying 
out baseline measurement once enough families have 
consented for randomisation to occur. Therapists and 
families preferred shorter sessions in community venues, 
predetermined shorter appointments are proposed for 
any subsequent trial. Challenges anticipated in recruiting 
for the definitive main trial will be addressed by using a 
community pathway for recruitment alongside using clin-
ical nurses to aid recruitment in clinical settings. In the 
current study, the community pathway was introduced 
Figure 3 SCORE-15 total mean change for Caregivers 
with low and high anxiety (a reduction=positive change; 
high anxiety >7 on GAD-7). GAD-7, Generalised Anxiety 
Disorder 7; SAFE, Systemic Autism- related Family Enabling; 
SCORE-15, Systemic CORE 15.
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later in the study and did boost recruitment. We will 
also encourage recruitment and clarity for families by 
developing a recruitment open day, screening tool and 
appointment system for SAFE sessions based on a clinic 
model influenced by potential benefits of family- centred 
service delivery.46 In the current study, families of children 
with autism were not eligible if their children had intellec-
tual disability or needed substantial support. Subsequent 
refinements of the intervention should address this issue 
to broaden the application of the intervention. Due to 
the lack of ethnic diversity in Plymouth and Cornwall our 
participants were all white. This will need to be addressed 
in any future trial. Given that prevalence differs between 
ethnic groups47–49 and beliefs and support networks may 
also differ, it is essential for appropriate implementation 
across the UK, and internationally, that any future trial 
reflects ethnic diversity. Any definitive trial will, therefore, 
include centres which have an ethnically diverse client 
base.
CONCLUSIONS
To our knowledge, this is the first study of family therapy 
as an intervention for families of children with a diagnosis 
of autism. The proposed primary outcome measure, the 
SCORE-15, indicated potential benefits for the inter-
vention group compared with controls in coping with 
problems, developing strengths and communicating 
within families. Qualitative data showed that family 
members felt the intervention improved understanding, 
communication, confidence, mental health, reflection, 
problem solving and sense of isolation. Attendance and 
completion of outcome measures was acceptable and 
NHS therapists were effectively skilled after receiving 
brief SAFE training. This study suggests that SAFE can 
address current gaps in recommended care postdi-
agnosis and can and should be subject to a definitive 
trial. The findings indicate that SAFE can be effectively 
and confidently delivered by existing NHS staff and has 
potential to be a feasible and beneficial treatment for 
these families.
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Appendix 1 
Brief Summary of INTERVENTION MANUAL for SAFE (Systemic Autism-
related Family Enabling): an early intervention for families of children with 
autism and Asperger Syndrome 
 
Professor Rudi Dallos and Doctor Rebecca McKenzie 
 
The intervention manual has been developed from the following bases of evidence 
and clinical experience: 
 
1. Systemic Family Therapy.  
Systemic Family Therapy focuses on promoting positive changes in the relationships within families 
rather than the isolated behavior of individuals in the family (Dallos & Draper, 2015).  Difficulties are 
seen to be maintained or exacerbated by family dynamics including the organization of families, 
communicational patterns and repetitive interaction sequences of problems. The combination of these is 
encapsulated in the idea of the formation of ineffective attempted solutions to their problems which 
rather than offering solutions can aggravate their difficulties. Systemic Family Therapy embodies a range 
of approaches and techniques for helping families to explore and re-organise their understanding, 
relationship patterns, emotional connections and problem-solving abilities. It typically involves a 
therapist and a supervision team working with one family at a time with close monitoring, based on 
feedback during and at the end of each session exploring the relevance, helpfulness and applicability of 
the therapy. Where supervision teams are not available a more flexible model -  ‘in room consultation’ 
can be employed whereby two therapists support each other in a structure where one therapist takes on 
the role of monitoring the family’s reactions as therapy proceeds and periodically offering feedback as a 
form of live supervision. A development of this orientation is Multi-Family Therapy whereby groups of 
families work together to assist and facilitate change, effectively acting as consultants for each other. The 
SAFE program employs both these versions of Systemic Family Therapy with three single family 
sessions to explore in detail each family’s needs; and two group sessions using concepts and techniques 
from Multi-Family Therapy 
 
2. Multi-Family Therapy 
Multi-Family Therapy is a recognised treatment approach which aims to provide a more empowering, 
flexible and intensive form of family intervention than single family therapy (Asen & Scholz, 2009). In 
Multi-Family Therapy similar techniques are employed to those used in single family therapy, but 
families are encouraged to work together, to be proactive in solving their own problems Multi-Family 
Therapy aims to help families rediscover their own resources by emphasising how families can take an 
active role in tackling dilemmas and assisting each other. At the same time families are encouraged to use 
the group setting to explore how problems have affected family life in consultation with other families 
and to share their solutions and competencies. This involves a power shift from the therapist-client 
relationship and encourages an empowering peer-support environment. The sharing of experiences and 
the dynamics of the group are important components of the treatment. 
3. Family Models 
The SAFE program incorporates a range of concepts and techniques by integrating systemic and 
attachment based family models, in particular The Circle of Security Intervention (Powell et al., 2014) 
and Attachment Narrative Therapy developed by co-applicant Professor Rudi Dallos (Dallos, 2006). In 
the SAFE intervention, these systemic and attachment models have been combined with an emphasis on 
visual materials and active, play-based approaches designed to be appropriate for families of children 
with autism. 
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4. Autism friendly 
SAFE has been developed in collaboration with children with autism and their families to be autism 
friendly. Given the evidence in the literature for a visual processing style, communication difficulties and 
restricted interests among people with autism, the advice of families is in line with current research. 
SAFE incorporates a multi-sensory approach using visual materials which are integrated into therapeutic 
techniques and play-based activities. SAFE also acknowledges and works with the children’s talents and 
areas of special interest. It also recognizes that parents are often extremely well-informed and prefer an 
approach which recognizes their competencies and helps them to feel empowered rather than de-skilled 
by therapy.  
 
 
 
SAFE sessions and examples of activities: 
 
SAFE involves 5 x 3-hour sessions outlined in a detailed manual. All sessions are facilitated by two 
therapists trained in the SAFE intervention model. Around 6 families receive the SAFE intervention as a 
cohort, supported by two therapists. Sessions 1 and 5 are based on Multi-Family Therapy and all parents 
from the 6 families attend. Sessions 2, 3 and 4 are for single families and all family members attend 
including siblings and/or grandparents if the family wish. So the 6 families meet each other at the 
beginning and the end but the in-between sessions are just for their own family. 
 
SAFE is supported by a detailed manual setting out a structure for each session and also a toolkit of 
activities which can be used flexibly according to family need and the age and symptoms of the child. 
 
Examples of activities include the following: 
 
 
Tracking a circularity 
 
Families explore the events of positive and problematic  cycles of events, such as ‘meltdowns’  by 
breaking these down to explore in detail  what happened, including  actions, understandings, 
expectations  and how people felt. E.g. what happened first, then what happened next? What did you 
do? What did Mum do? This can allow families to unpick problematic and successful cycles and initiate 
positive change. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mum 
said let's 
go for a 
walk 
I said I 
was 
busy
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Button Sculpt 
 
Families use buttons to map and discuss relationships (how 
close they are to each other) before and after the diagnosis 
and how they predict it might be in the future. This helps to 
the families understand the relationships, feelings and 
perceptions at key times and also reflect on how these may 
change and develop. 
 
 
 
 
Additional activities 
 
Role play 
Often used with tracking to try out new approaches or rehearse successful interactions or strategies. 
 
Reflective conversations 
Therapists have a conversation about their thoughts on the family issues and dynamics. The family 
are invited to listen and then to discuss between themselves and the therapists what was of interest 
and relevant, what they agreed or disagreed with etc. This is an opportunity to build a sense of 
openness, support the therapeutic relationships, validate the family, praise successes and also to offer 
specific suggestions. 
 
Drawing 
Family members draw aspects of their life e.g. a typical day or a day at school. Drawing can also be 
used as part of SAM if the child wishes to draw autism or themselves as part of the activity. 
 
Video feedback activities 
Families watch video training materials of other families and use tracking techniques to analyse what 
is happening, make connections with their own experience and suggest ways forward. This is used in 
sessions 1 and 5 with the parents. They are asked to watch videos of a child and mum dealing with a 
meltdown and in the final session a young person with autism describing how he manages emotional 
and sensory difficulties. These activities are intended to help reflection in a non-challenging way and 
empower parents to act as consultants to others in similar positions. 
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